-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.
-
Summary
-
Immunovant, Inc. quarterly/annual General and Administrative Expense history and growth rate from 2018 to 2023.
- Immunovant, Inc. General and Administrative Expense for the quarter ending March 31, 2024 was $14.8 M, a 19.3% increase year-over-year.
- Immunovant, Inc. General and Administrative Expense for the twelve months ending March 31, 2024 was $57.3 M, a 19.3% increase year-over-year.
- Immunovant, Inc. annual General and Administrative Expense for 2023 was $57.3 M, a 19.3% increase from 2022.
- Immunovant, Inc. annual General and Administrative Expense for 2022 was $48 M, a 11.4% decline from 2021.
- Immunovant, Inc. annual General and Administrative Expense for 2021 was $54.2 M, a 37.2% increase from 2020.
General and Administrative Expense, Trailing 12 Months (USD)
General and Administrative Expense, Annual (USD)
General and Administrative Expense, YoY Annual Growth (%)